ClinicalTrials.gov record
Completed Phase 2 Interventional

Evaluating the Dietary Supplement Anatabloc in Thyroid Health-ASAP (Antabloc Supplementation Autoimmune Prevention)

ClinicalTrials.gov ID: NCT01551498

Public ClinicalTrials.gov record NCT01551498. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 6:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Trial to Evaluate the Safety and Potential Effects of the Dietary Supplement Anatabloc on Antithyroid Autoantibodies and Thyroid Function in Autoimmune Thyroiditis

Study identification

NCT ID
NCT01551498
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Rock Creek Pharmaceuticals, Inc.
Industry
Enrollment
165 participants

Conditions and interventions

Interventions

  • Anatabloc Supplement Dietary Supplement
  • Placebo Dietary Supplement

Dietary Supplement

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2012
Primary completion
Dec 31, 2012
Completion
Jan 31, 2013
Last update posted
Nov 1, 2015

2012 – 2013

United States locations

U.S. sites
9
U.S. states
5
U.S. cities
8
Facility City State ZIP Site status
Metabolic Research Institute, Inc. West Palm Beach Florida 33401
Florida Medical Clinic, P.A. Zephyrhills Florida 33542
Robert J. Becker, M.D., LTD La Grange Illinois 60561
Associated Endocrinologists, P.C. West Bloomfield Michigan 48322
New Jersey Physicians, LLC Clifton New Jersey 07012
Texas Diabetes & Endocrinology Austin Texas 78731
North Texas Endocrine Center Dallas Texas 75231
Research Institute of Dallas Dallas Texas 75231
Texas Diabetes & Endocrinology Round Rock Texas 78681

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01551498, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2015 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01551498 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →